Brief: Ambalal Sarabhai Enterprises Says Cosara Diagnostics Gets Clearance For 5 Tests To Be Made, Sold As In Vitro Diagnostics From Ranoli Facility
Dec 2 (Reuters) - Ambalal Sarabhai Enterprises Ltd
AMBL.BO :
* AMBALAL SARABHAI ENTERPRISES-COSARA DIAGNOSTICS GOT
REGULATORY
CLEARANCE FOR 5 TESTS TO BE MADE, SOLD AS IN VITRO DIAGNOSTICS
FROM FACILITY IN RANOLI
Source text for Eikon: ID:nBSEb1tn13
Further company coverage: AMBL.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ambalal Sarabhai Enterprises
See all newsBrief: Ambalal Sarabhai Enterprises Says Telerad Division Of Unit Signs Agreement With Bolin Technology
Brief: Ambalal Sarabhai Enterprises Says CFO Navinchandra Patel Resigns
Brief: Ambalal Sarabhai Enterprises Names Mohal K. Sarabhai As MD
Brief: Ambalal Sarabhai Enterprises Says Unit Asence Pharma Commences New Oncology And Synthetic API Plant At Ranoli, Vadodara
Brief: India's Ambalal Sarabhai Enterprises Dec-Qtr Consol Net Profit Falls